Flaschka G, Marth E, Desoye G, Freidl W, Walzl M
Universitäts-Klinik für Neurochirurgie, Graz.
Zentralbl Neurochir. 1990;51(3):129-37.
In a review of the literature the current knowledge of the diagnostic significance of sialic acid (NANA), neuron-specific enolase (NSE) and carcinoembryonic antigen (CEA) in the detection and differentiation of brain tumors is demonstrated. The efficiency of some additional biochemical tumor markers is briefly described. In a total of 101 patients of our own 63 patients operated on intracranial expansive lesions and 38 patients with non-tumoral diseases of the central nervous system were examined for their serum concentrations of NANA, NSE and CEA with additional determination of total serum protein (TSP) and C-reactive protein (CRP) concentrations. 24 benign, 15 semibenign, 12 semimalign and 12 malign expansions were compared with each other and with the controls for their tumor marker concentrations. The criteria of the diagnostic reliability (sensitivity, specificity, positive and negative predictive value) were calculated for each single marker and the reliability of information for the combined used markers was evaluated. In summary the following results were found: The concentration of C-reactive protein corresponded significantly with the NANA-concentrations on the one hand and with the CEA-concentrations on the other hand (p less than 0.05). NANA: 1. The average concentration increased with increasing malignancy (no significance). 2. Patients who suffered from non-tumorous diseases of the central nervous system which coincided with brain tissue lesions had often extremely high values. 3. 4 of 10 healthy controls had NANA-levels above the reference value. 4. The sensitivity was 44%, the specificity 73%, the positive predictive value 17%, the negative predictive value 88% (patients with pathological CRP- or TSP-values excluded).(ABSTRACT TRUNCATED AT 250 WORDS)
在一篇文献综述中,阐述了目前关于唾液酸(NANA)、神经元特异性烯醇化酶(NSE)和癌胚抗原(CEA)在脑肿瘤检测与鉴别诊断中的意义的知识。简要描述了一些其他生化肿瘤标志物的效能。在我们自己的101例患者中,对63例接受颅内占位性病变手术的患者以及38例患有中枢神经系统非肿瘤性疾病的患者,检测了他们血清中NANA、NSE和CEA的浓度,并额外测定了血清总蛋白(TSP)和C反应蛋白(CRP)的浓度。将24例良性、15例半良性、12例半恶性和12例恶性占位性病变彼此之间以及与对照组的肿瘤标志物浓度进行了比较。计算了每个单一标志物的诊断可靠性标准(敏感性、特异性、阳性和阴性预测值),并评估了联合使用标志物的信息可靠性。总之,得出以下结果:C反应蛋白浓度一方面与NANA浓度显著相关,另一方面与CEA浓度显著相关(p小于0.05)。NANA:1. 平均浓度随恶性程度增加而升高(无显著性)。2. 患有与脑组织病变同时存在的中枢神经系统非肿瘤性疾病的患者,其值往往极高。3. 10名健康对照中有4人NANA水平高于参考值。4. 敏感性为44%,特异性为73%,阳性预测值为17%,阴性预测值为88%(排除CRP或TSP值异常的患者)。(摘要截短于250字)